Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label Study Of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) To Evaluate Hematologic Response Rate In Anemic Cancer Patients Receiving Chemotherapy

NCT00315484 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00315484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label Study Of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) To Evaluate Hematologic Response Rate In Anemic Cancer Patients Receiving Chemotherapy
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
October 31, 2004
Enrollment
358 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chemotherapy